AccelLAB Management Acquires AccelLAB from Charles River Laboratories
January 18, 2024
Key members of AccelLAB's management team acquired AccelLAB from Charles River Laboratories, and the business will operate independently as a standalone preclinical CRO serving the medical device and biologics markets. Fairmount Partners served as exclusive financial advisor to Charles River in the divestiture; AccelLAB employs approximately 100 staff across facilities in Boisbriand and Terrebonne, Quebec, Canada.
- Buyers
- Key members of the AccelLAB management team
- Targets
- AccelLAB
- Sellers
- Charles River Laboratories
- Industry
- Medical Devices
- Location
- Quebec, Canada
- Transaction Type
- Divestiture
Explore More
Related Acquisitions
-
Charles River Laboratories Acquires Explora BioLabs
April 6, 2022
Biotechnology
Charles River Laboratories has acquired Explora BioLabs Holdings, a San Diego–based provider of contract vivarium services, for approximately $295 million in cash. The deal expands Charles River’s CRADL footprint with more than 15 additional vivarium facilities (bringing expected combined capacity to at least 25 sites and ~300,000 sq ft by end of 2022) and adds complementary preclinical vivarium management capabilities and clients.
-
Charles River Laboratories Acquires Cellero
August 6, 2020
Biotechnology
Charles River Laboratories (CRL) completed the acquisition of Cellero, a provider of donor and patient apheresis services, GMP-grade biomaterials, and custom laboratory services, for approximately $38 million in cash. The purchase, from Ampersand Capital Partners, expands Charles River's capabilities and offerings in cell and gene therapy support services worldwide.
-
FairJourney Biologics Acquires Charles River Laboratories' South San Francisco Facility
March 3, 2025
Biotechnology
FairJourney Biologics S.A. has acquired Charles River Laboratories' South San Francisco site (formerly Distributed Bio), including facilities, staff, assets and proprietary antibody libraries and yeast display technology. The acquisition expands FairJourney's antibody discovery and engineering capabilities and establishes a strategic presence in a major U.S. biotech hub to better serve biopharma customers.
-
Calibre Scientific Acquires Camlab Limited
April 29, 2024
Healthcare Services
Calibre Scientific has acquired Camlab Limited, a Cambridge-based supplier of scientific equipment, chemicals, consumables, PPE, labware and associated services. The acquisition expands Calibre Scientific’s product and service footprint in the United Kingdom and adds local service capabilities such as repairs, maintenance and calibration to its global life-science distribution platform.
-
Charles River Laboratories Acquires Cognate BioServices
February 17, 2021
Biotechnology
Charles River Laboratories agreed to acquire Cognate BioServices for approximately $875 million in cash, expanding Charles River's capabilities into the high-growth cell and gene therapy CDMO sector. Cognate, headquartered in Memphis, Tennessee with over 500 employees, will provide Charles River integrated cell and gene therapy development, testing, and CGMP manufacturing capabilities; the deal was expected to close by end of Q1 2021.
-
Calibre Scientific Acquires Dynalab Corp.
January 10, 2023
Manufacturing
Calibre Scientific has acquired Dynalab Corp., a Rochester, New York-based distributor and manufacturer of laboratory plastics, consumables, equipment and custom fabricated products. The deal marks Calibre Scientific's debut into the United States distribution market, expanding its product portfolio and North American distribution capabilities while creating cross-selling opportunities across its global platform.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.